150 related articles for article (PubMed ID: 21714686)
21. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
22. Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial.
Mirmiran P; Fazeli MR; Asghari G; Shafiee A; Azizi F
Br J Nutr; 2010 Aug; 104(3):402-6. PubMed ID: 20334708
[TBL] [Abstract][Full Text] [Related]
23. The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen.
Urban D; Irwin W; Kirk M; Markiewicz MA; Myers R; Smith M; Weiss H; Grizzle WE; Barnes S
J Urol; 2001 Jan; 165(1):294-300. PubMed ID: 11125428
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.
Gleave ME; Goldenberg SL; Chin JL; Warner J; Saad F; Klotz LH; Jewett M; Kassabian V; Chetner M; Dupont C; Van Rensselaer S;
J Urol; 2001 Aug; 166(2):500-6; discussion 506-7. PubMed ID: 11458055
[TBL] [Abstract][Full Text] [Related]
25. Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy.
Beer TM; Myrthue A; Garzotto M; O'hara MF; Chin R; Lowe BA; Montalto MA; Corless CL; Henner WD
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2225-32. PubMed ID: 15598784
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
Pantuck AJ; Leppert JT; Zomorodian N; Aronson W; Hong J; Barnard RJ; Seeram N; Liker H; Wang H; Elashoff R; Heber D; Aviram M; Ignarro L; Belldegrun A
Clin Cancer Res; 2006 Jul; 12(13):4018-26. PubMed ID: 16818701
[TBL] [Abstract][Full Text] [Related]
27. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
[TBL] [Abstract][Full Text] [Related]
28. Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.
Pili R; Häggman M; Stadler WM; Gingrich JR; Assikis VJ; Björk A; Nordle O; Forsberg G; Carducci MA; Armstrong AJ
J Clin Oncol; 2011 Oct; 29(30):4022-8. PubMed ID: 21931019
[TBL] [Abstract][Full Text] [Related]
29. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
[TBL] [Abstract][Full Text] [Related]
30. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
Ide H; Tokiwa S; Sakamaki K; Nishio K; Isotani S; Muto S; Hama T; Masuda H; Horie S
Prostate; 2010 Jul; 70(10):1127-33. PubMed ID: 20503397
[TBL] [Abstract][Full Text] [Related]
31. Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.
Pruthi RS; Derksen JE; Moore D; Carson CC; Grigson G; Watkins C; Wallen E
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2172-7. PubMed ID: 16609031
[TBL] [Abstract][Full Text] [Related]
32. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
Zhang G; Qin L; Shi Y
J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678
[TBL] [Abstract][Full Text] [Related]
33. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women.
Komesaroff PA; Black CV; Cable V; Sudhir K
Climacteric; 2001 Jun; 4(2):144-50. PubMed ID: 11428178
[TBL] [Abstract][Full Text] [Related]
34. Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy.
Smith MR; Manola J; Kaufman DS; George D; Oh WK; Mueller E; Slovin S; Spiegelman B; Small E; Kantoff PW
Cancer; 2004 Oct; 101(7):1569-74. PubMed ID: 15468186
[TBL] [Abstract][Full Text] [Related]
35. Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasma antioxidant potential in dyslipidemic subjects.
Bertipaglia de Santana M; Mandarino MG; Cardoso JR; Dichi I; Dichi JB; Camargo AE; Fabris BA; Rodrigues RJ; Fatel EC; Nixdorf SL; Simão AN; Cecchini R; Barbosa DS
Nutrition; 2008 Jun; 24(6):562-8. PubMed ID: 18455656
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
Henning SM; Wang P; Said JW; Huang M; Grogan T; Elashoff D; Carpenter CL; Heber D; Aronson WJ
Prostate; 2015 Apr; 75(5):550-9. PubMed ID: 25545744
[TBL] [Abstract][Full Text] [Related]
37. Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins--a placebo-controlled and double blind study.
Richelsen B; Kristensen K; Pedersen SB
Eur J Clin Nutr; 1996 Dec; 50(12):811-5. PubMed ID: 8968702
[TBL] [Abstract][Full Text] [Related]
38. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
39. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
[TBL] [Abstract][Full Text] [Related]
40. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]